Related Experiment Video
Updated: Jun 17, 2026
08:05
Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
Published on: November 21, 2025
Ischemic compression block attenuates mechanical hyperalgesia evoked from latent myofascial trigger points
Yong-Hui Wang1, Xin-Li Ding, Yang Zhang
1Department of Physical Medicine and Rehabilitation, Qilu Hospital, Medical School of Shandong University, 250012 Jinan, People's Republic of China.
Experimental Brain Research
|December 26, 2009
Summary
Large-diameter myelinated muscle afferents are implicated in myofascial trigger points (MTrPs). Blocking these afferents increased pain thresholds at MTrP sites, suggesting their role in MTrP pain and hyperalgesia.
Area of Science:
- Neuroscience
- Physiology
- Pain Research
Background:
- Myofascial trigger points (MTrPs) are associated with localized pain and hypersensitivity.
- The specific neural mechanisms underlying MTrP pathophysiology remain incompletely understood.
Purpose of the Study:
- To investigate the role of large-diameter myelinated muscle afferents in the development and maintenance of MTrPs.
- To test the hypothesis that these afferents contribute to MTrP pain and mechanical hyperalgesia.
Main Methods:
- Utilized ischemic compression blockage (ICB) via tourniquet to selectively block large-diameter myelinated muscle afferents in 20 healthy subjects.
- Measured pressure pain threshold (PPT) and pressure threshold for referred pain (PTRP) in brachioradialis muscle MTrP regions.
- Compared measurements in MTrP regions with non-MTrP regions in a randomized, crossover design.
Main Results:
- ICB significantly increased PPT and PTRP at MTrP regions (P < 0.001).
- No significant changes in PPT were observed at non-MTrP regions following ICB.
- These findings indicate a specific involvement of large-diameter muscle afferents in MTrP-related pain sensitivity.
Conclusions:
- Large-diameter myelinated muscle afferents play a crucial role in the pain and mechanical hyperalgesia associated with myofascial trigger points.
- Targeting these afferents may offer a potential therapeutic strategy for MTrP management.
Related Concept Videos
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:30Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...